🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

UV-Trichoscopic Red Fluorescence in Alopecia Areata

Recruitingn/aAges 18 Years - anyAllIstanbul Training and Research Hospital
NCT07803874 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn whether red fluorescence seen with ultraviolet (UV) trichoscopy is related to disease findings and treatment response in adults with limited plaque-type alopecia areata. Trichoscopy is a close-up imaging method used to examine the hair and scalp. The study will investigate whether the amount of red fluorescence at the beginning of the study is related to how soon hair starts to grow back, how much hair regrows, and how trichoscopic findings change during follow-up. Participants for whom intralesional corticosteroid treatment has been planned as part of their regular medical care will have standard trichoscopic and UV-trichoscopic images taken of the affected scalp area. They will be followed at weeks 4, 8, and 12, when hair regrowth and changes in scalp and hair findings will be evaluated. Researchers will measure red fluorescence in the i

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 18 years or older * Limited plaque-type alopecia areata of the scalp * Active hair loss * Symptom onset within the previous 6 months * No topical, intramuscular, or oral treatment for alopecia areata within the previous 1 month * No intralesional corticosteroid treatment within the previous 6 weeks * Provision of informed consent Exclusion Criteria: * Beard alopecia areata * Very extensive alopecia areata or multiple large plaques * Tinea capitis or active infection * Current phototherapy * Systemic immunosuppressive treatment within the washout period specified in the study protocol * Pregnancy or breastfeeding * Contraindication to UV imaging
💊

What it tests

  • Triamcinolone Acetonide
📍

Where

1 site
Istanbul Training and Research Hospital
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy